Create a free account or log in.
We are committed to providing women new choices improving their daily life
For over twenty years, Mithra has dedicated its researches so as to redefine women’s health by bringing innovative products in the fields of contraception and menopause.
Today, Mithra counts two complementary platforms: its portfolio of innovative products based on Estetrol (E4) and its portfolio of Complex Therapeutics. The whole supported by the Mithra CDMO, a technological platform offering a wide range of services going from pharmaceutical development to commercial manufacturing.
Since the launch of the first generic contraceptive pill in Belgium, Mithra always focused on innovation for women.
After years of research and development, our pipeline today includes late-stage development products, potential blockbusters and complex therapeutics in the fields of contraception and menopause. These projects are powered by our Mithra CDMO, our unique R&D and manufacturing platform.
350
Worldwide
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
| Person (Position) | Type | Volume | Price | Date |
|---|---|---|---|---|
|
◆
NOSHAQ SA
(Board)
|
Other | EUR 617,814.92 | EUR 3.58 | 17.01.23 |
|
◆
NOSHAQ SA
(Board)
|
Other | EUR 1,052,701.40 | EUR 6.10 | 17.11.22 |
|
◆
NOSHAQ SA
(Board)
|
Other | EUR 1,006,250.00 | EUR 6.44 | 18.07.22 |
|
◆
NOSHAQ SA
(Board)
|
Other | EUR 1,239,062.50 | EUR 7.93 | 13.05.22 |
|
↓
Gordenne Valérie
(Other)
|
Sell | EUR 87,380.00 | EUR 10.28 | 13.04.22 |
|
↓
Fornieri Francesco
(Board)
|
Sell | EUR 1,312,000.00 | EUR 13.12 | 29.03.22 |
|
↓
Fornieri Francesco
(Board)
|
Sell | EUR 486,530.57 | EUR 13.56 | 25.03.22 |
|
↓
Fornieri Francesco
(Board)
|
Sell | EUR 219,536.19 | EUR 14.02 | 24.03.22 |
|
↓
Fornieri Francesco
(Board)
|
Sell | EUR 39,452.00 | EUR 14.00 | 24.03.22 |
|
↓
Fornieri Francesco
(Board)
|
Sell | EUR 178,230.75 | EUR 14.23 | 23.03.22 |
ABVX
Sector
Health Care
Country
France
ISIN
FR0012333284
Founded
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …
ADXN
Sector
Health Care
Country
Switzerland
ISIN
CH0029850754
Founded
2002
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …
AEGIR
Sector
Health Care
Country
Sweden
ISIN
SE0014401121
Founded
2019
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …
ANIC
Sector
Health Care
Country
Isle of Man
ISIN
Founded
Allergy Therapeutics PLC: Global immunology leader, researching, developing, and manufacturing convenient allergy treatments.Ê Our mission: Transforming lives through innovative immunotherapy.
AIEA
Sector
Health Care
Country
United Kingdom
ISIN
Founded
Alliance Pharma PLC improves lives through clinically valuable healthcare products. We market consumer & prescription medicines, leveraging an asset-light model …
ALK
Sector
Health Care
Country
North Macedonia
ISIN
MKALKA101011
Founded
1936
Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …